BMY
Bristol-Myers Squibb Co
Price:  
59.38 
USD
Volume:  
4,581,564.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy Probability of Bankruptcy

The Probability of Bankruptcy of Bristol-Myers Squibb Co (BMY) is 12.75% . This number represents the probability that Bmy will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating Bmy's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

Bmy - ESG ratings

ESG ratings are directly linked to the cost of capital and Bmy's ability to raise funding, both of which can significantly affect the probability of Bristol-Myers Squibb Co going bankrupt.

ESG Score 75.78
Environment Score 78.06
Social Score 85.84
Governance Score 63.43
Returns
Historical Returns (5 day) -0.93%
Historical Returns (MTD) 0.27%
Historical Returns (YTD) 15.73%
Historical Returns (13 week) 21.93%
Historical Returns (26 week) 42.23%
Historical Returns (52 week) 18.38%
Efficiency
Asset Turnover 0.50
Receiveable Turnover 5.12
Gross Margin 75.87%
Operating Margin -12.02%
Pretax Margin -14.50%
Net Margin -15.30%
Return on Asset (ROA) -7.59
Return on Equity (ROE) -36.26
Return on Investments (ROI) -10.46
Price Metrics
Market Cap (M) 120,433.33
Enterprise Value (M)
52 Week High 61.08
52 Week Low 39.35
Beta -0.14
Average Volume (10 day) 2.54
Average Volume (3 month) 2.92
Price / Earnings (P/E)
Price / Sales (P/S) 2.54
Earnings
EPS -3.60
Revenue CAGR (5 year) 14.81%
Risk
Current Ratio 1.24
Quick Ratio 1.09